The meeting comes after U.S. and Ukrainian officials sought to narrow the gaps between them over a plan to end the war in Ukraine, agreeing to modify a U.S. proposal that Kyiv and its European allies saw as a Kremlin wish list.

The former Bank of England economist - the first female chancellor of the exchequer - has staked her political identity on being the antidote to the chaos that roiled British politics in recent years.

The head of a British employers group accused the finance minister of ignoring business on issues such as a plan to give workers more rights.

With his own presidency at stake, Trump is calling candidates, making early endorsements, and pushing economic messaging to try to keep Congress in Republican hands.

Venezuela's government rejected what it called a "ridiculous" U.S. plan to designate the "non-existent" group.

A four-judge panel of Brazil's Supreme Court voted unanimously on Monday to keep former President Jair Bolsonaro in police custody after Justice Alexandre de Moraes ordered his detention on Saturday citing a flight risk.

Israeli forces killed three Palestinians in Gaza near the line demarcating areas of Israeli control on Monday, underlining the struggle to broaden a fragile ceasefire deal approved over six weeks ago to global acclaim.

The Gaza Humanitarian Foundation, the U.S.- and Israeli-backed organisation to distribute aid in Gaza, said on Monday it was ending its operations after months of criticism over deaths of hundreds of Palestinians trying to reach GHF hubs.

Unprecedented numbers of Americans are expected to hit stores this Black Friday, but they are likely to curtail their spending as they find fewer bargains from tariff-hit retailers.

Officials from several U.S. states say Americans relying on subsidies to afford Obamacare health insurance are holding off on enrolling as they face 2026 premium hikes that could more than double, with one state seeing enrollment drag by as much as 33%.

Novo Nordisk's closely watched Alzheimer's trials of an older oral version of its semaglutide drug failed to help slow the progression of the brain-wasting disease, the firm said on Monday, sending the obesity drugmaker's shares sliding.

The U.S. Food and Drug Administration has approved Novartis' gene therapy for patients with a rare muscle disorder, the drugmaker said on Monday.

Shantanu Narayen's shift to subscriptions was so influential that the $135 bln software developer became a case study for training CEO wannabes. AI has now sparked a race to blaze a new trail. A repeat, partly by charging a premium for someone else's tech, would be quite a feat.

Portland Trail Blazers coach Chauncey Billups pleaded not guilty in Brooklyn federal court on Monday in a sweeping criminal case accusing the NBA Hall of Famer of conspiring with the mafia to rig illicit poker games.